image credit: Unsplash

EMA backs Pfizer’s RSV vaccine for use during pregnancy

July 21, 2023


Adults over the age of 60 now have two RSV vaccines to choose from in the U.S. and Europe. A new antibody treatment is available to prevent infants from infections, too.

So far, Pfizer is the only drugmaker to reach regulators with a candidate for use in pregnant people, which could give another option for protecting newborns. GSK, which won approval of its RSV vaccine in older adults, was also testing a candidate in pregnant women up until last year, when it halted testing for a safety review.

Read More on Biopharma Dive